The Centers for Disease Control and Prevention estimate that roughly 476,000 Americans are diagnosed and treated for Lyme disease each year. A meaningful share of those patients go on to experience persistent symptoms long after their initial treatment ends.
Symptoms span fatigue, joint pain, neurological changes, mood shifts, immune problems, and disrupted sleep. For many patients, these symptoms cross multiple organ systems, involve multiple specialists, and expose gaps in a care system never designed to manage them together.
Celly Health was.
Lyme disease and the additional infections that often travel with it are complex by nature. Managing them well takes a coordinated team with the clinical expertise to assess every dimension of the condition — and the infrastructure to deliver on that assessment.
Patients with chronic Lyme often spend years cycling through specialists before receiving an accurate diagnosis. Many are told their symptoms reflect autoimmune disease, fibromyalgia, chronic fatigue syndrome, or a psychiatric condition — when an underlying infection is actually driving the illness. The result is prolonged disability, lost productivity, and significant out-of-pocket cost.
Communities with limited access to specialty care carry this burden disproportionately. The Celly Health model is designed to close that gap, bringing experienced specialist care and coordinated support to every patient — across all 50 states and the District of Columbia.
Celly Health accepts referrals for patients with suspected or confirmed tick-borne illness, lingering symptoms after Lyme treatment, and chronic whole-body symptoms of unclear origin. A dedicated care coordination team manages the transition and keeps referring providers informed with a clear, active care plan.
Call our dedicated Lyme & Tick-Borne Illness Team for more information. Book by phone or schedule your initial consultation online.
Lyme disease is caused by a bacteria called Borrelia, transmitted primarily through tick bites. Many patients never recall a tick bite, and many never develop the well-known bull's-eye rash.
Once Lyme is established in the body, the bacteria can hide from the immune system, settle into tissue, and trigger inflammation that affects multiple systems at once. Standard short-course antibiotics often fall short — particularly when other tick-borne infections are also present, such as Bartonella, Babesia, or Mycoplasma.
Standard Lyme testing relies on a two-step blood test that measures antibodies — the proteins your immune system makes in response to an infection. The challenge is that antibodies are not the infection itself. They are only a signal that your body recognized one.
When the immune system is run down (as often happens in chronic Lyme), antibody levels can be too low to register a positive result. Standard panels also screen for only a limited set of Lyme strains and miss most of the additional tick-borne infections that travel alongside it. The result: patients with active infections are routinely told they don't have Lyme. Lyme requires integrated, adaptive care — because no two cases look alike.
Lyme has been called The Great Imitator for a reason. Patients are often misdiagnosed with:
At Celly Health, we evaluate for tick-borne illness whenever the clinical picture warrants it — regardless of any prior diagnosis a patient arrives with.
Celly Health applies advanced diagnostics and integrative care to help you regain your health.
Start Your Evaluation